ID
33000
Beschreibung
Study ID: 101877 Clinical Study ID: SAS101877 Study Title: A randomised, open label, 5-way crossover study to assess the systemic exposure of FP and salmeterol from SERETIDE/ADVAIR 250 without spacer, with Aerochamber -Plus and with -Max spacer, with VOLUMATIC spacer and SERETIDE/ADVAIR 500 DISKUS/ACCUHALER in adult subjects with mild or intermittent asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Advair DISKUS,Seretide Accuhaler; Viani,Seretide Diskus,Seretide Accuhaler,Seretide,Advair DISKUS Study Indication: Asthma The study consists of 5 treatment periods and a follow-up visit. The Screening includes Session 1 Treatment Period 1 includes Session 2 Treatment Period 2 includes Session 3 Treatment Period 3 includes Session 4 Treatment Period 4 includes Session 5 Treatment Period 5 includes Session 6 The Follow-up includes Session 7. This document contains the form for pharmacokinetic blood sampling,investigational products and their administration. It has to be filled in for session 2-6.
Stichworte
Versionen (3)
- 15.11.18 15.11.18 -
- 22.11.18 22.11.18 -
- 23.11.18 23.11.18 - Sarah Riepenhausen
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
23. November 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Systemic exposure of fluticasone propionate (FP) and salmeterol from different inhalation devices in adults with mild or intermittent asthma, (Study-)ID: 101877
Pharmacokinetic Blood Sampling, lnvestigational Product
- StudyEvent: ODM
Beschreibung
Pharmacokinetic Blood Sampling
Alias
- UMLS CUI-1
- C0031328
- UMLS CUI-2
- C0005767
- UMLS CUI-3
- C0870078
Beschreibung
Row no.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0237753
Beschreibung
day month year.
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0031328
- UMLS CUI [1,2]
- C0005767
- UMLS CUI [1,3]
- C0870078
- UMLS CUI [1,4]
- C0011008
Beschreibung
time relative to dosing
Datentyp
integer
Alias
- UMLS CUI [1]
- C0439564
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1]
- C0040223
Beschreibung
Sample number
Datentyp
integer
Alias
- UMLS CUI [1]
- C1299222
Beschreibung
Tick if taken. Please take for sample number BLD001, BLD003-BLD013. It does not have to be taken for sample number BLD002.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0117996
- UMLS CUI [1,2]
- C0200345
Beschreibung
Tick if taken. Please take for sample number BLD001-BLD006 and BLD008. It does not have to be taken for: BLD007, BLD009-BLD013
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0073992
- UMLS CUI [1,2]
- C0200345
Beschreibung
lnvestigational Product
Alias
- UMLS CUI-1
- C0304229
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0040223
Beschreibung
Number of inhalations
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0354922
- UMLS CUI [1,2]
- C0237753
Beschreibung
Significant changes refer to investigational product not administered as per the requirements of the protocol.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C3845681
- UMLS CUI [1,2]
- C0304229
Beschreibung
Specify investigational product change
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C3845681
- UMLS CUI [1,3]
- C0304229
Beschreibung
lnvestigational Product Administration Worksheet
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1533734
Beschreibung
Tick appropriate box(es). Each participant of the study will use each of the 5 application methods in the course of the study. Which method will be used during which treatment period is determined by randomization.
Datentyp
text
Alias
- UMLS CUI [1]
- C0304229
Beschreibung
initials
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0027361
- UMLS CUI [1,3]
- C1533734
Beschreibung
initials
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1621583
- UMLS CUI [1,3]
- C1283174
Ähnliche Modelle
Pharmacokinetic Blood Sampling, lnvestigational Product
- StudyEvent: ODM
C0005767 (UMLS CUI-2)
C0870078 (UMLS CUI-3)
C0005767 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C3845681 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C1533734 (UMLS CUI-2)
C0027361 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,3])
C1621583 (UMLS CUI [1,2])
C1283174 (UMLS CUI [1,3])